The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion, and BMS’ […]

The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide […]

Scaling Flow Chemistry for Sustainability, Safety and Speed to Market  With the growing demand for better flow technology, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into […]